What STADA Poland does

STADA Poland is the Polish subsidiary of STADA Arzneimittel AG, a German pharmaceutical conglomerate listed on the Frankfurt Stock Exchange and operating in approximately 120 countries with roughly 12,300 employees worldwide. The Polish business markets prescription medicines, over-the-counter (OTC) drugs, medical devices, cosmetics and dietary supplements across cardiovascular, pain/CNS, dermatology, respiratory, and consumer health categories, serving both pharmacy retailers and end consumers in Poland through wholesale intermediaries (e.g., NEUCA) and an in-house field sales organization.

The portfolio is built on a mix of STADA-developed generics and a series of established consumer healthcare brands acquired from major pharmaceutical companies between March and October 2020 — Walmark, plus Cholinex, Orofar and Venoruton from GSK, Nizoral from Johnson & Johnson, and Modafen and Acodin from Sanofi. Additional pipeline exposure to specialty and biologic therapeutics is being built through biosimilar development partnerships with Alvotech, mAbxience (Insud) and Xbrane. The Polish operations are headquartered in Warsaw (ul. Krakowiaków 44, 02-255 Warszawa), with two legal entities (STADA Pharm Sp. z o.o. and STADA Poland Sp. z o.o.) whose announced merger was dated September 26, 2023; a new office was opened at The Park Warsaw in May 2021, and Paulina Romaniszyn has served as Country Head & General Manager since September 2020.

The business model is one-time product sales through pharmacy distribution channels, with revenue generated when wholesalers and pharmacies purchase branded generics, OTC SKUs, and consumer healthcare products for resale to Polish consumers. The company pursues growth through brand acquisitions, geographic and category expansion of the consumer health portfolio, and pipeline additions via biosimilar partnerships, while leveraging the parent group's scale in regulatory affairs, manufacturing, and supply chain to compete with both local Polish generics manufacturers and larger multinational pharmaceutical companies.

Name

STADA Poland

Legal name

STADA Pharm Sp. z o.o.

Website

https://www.stadapoland.pl

Company type

Private

Operating status

Operating

Short description

STADA Poland is the Polish subsidiary of German pharmaceutical conglomerate STADA Arzneimittel AG, marketing prescription drugs, OTC products, medical devices, cosmetics, and dietary supplements through pharmacy wholesale channels across Poland.

Ownership category

akta.pro rank

Product category

Generic and specialty pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Generic Hospital & Institutional Products (HLAIABAL)

akta.pro secondary industries

Specialty Care Pharmaceuticals (HLAIAAAB), Specialty Condition Supplements (Sleep, Stress, Heart, Joint, Gut, Immunity) (CRADAGAE)

Keywords

• Generic pharmaceuticals
• OTC consumer healthcare
• Prescription medicines
• Medical devices
• Dietary supplements

Headquarters

HQ city

Warszawa

HQ country

Poland

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Marketing or Sales, Operations, Technology or R&D

Revenue model

1. Pharmaceutical Product Sales: STADA Poland generates revenue through the sale of prescription medications (leki na receptę), OTC products (leki bez recepty), medical devices (wyroby medyczne), cosmetics (kosmetyki), and dietary supplements (suplementy diety). The company operates a two-pillar strategy covering generic drugs including specialist medicines and consumer healthcare products available without prescription.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

STADA Poland develops and markets a two-pillar portfolio of (1) generic and specialty prescription medicines covering pain, cardiovascular, CNS, urology, oncology, and infectious disease therapeutics, and (2) consumer healthcare OTC products, medical devices, cosmetics, and dietary supplements. Its products are sold through pharmaceutical wholesalers and pharmacy retail in Poland under established brands such as Cholinex, Orofar, Nizoral, ITAMI, Venoruton, Mobilat, Hirudoid, Oilatum, Sinulan, and Hedrin.

Product overview

STADA Poland operates as part of STADA AG, a German pharmaceutical conglomerate, offering a two-pronged strategy covering generic medicines (including specialty pharmaceuticals) and consumer healthcare products available without prescription. The company provides prescription medications across therapeutic areas including cardiovascular health (anticoagulants like Dabigatran and Axipio, pain management like Tramal and Palexia), central nervous system disorders, urology, and diabetes. The OTC portfolio includes throat lozenges (Cholinex, Orofar), dermatological products (Nizoral for antifungal treatment), muscle and joint treatments (ITAMI, Mobilat, Elmetacin), and venous products (Hirudoid, Venoruton). Medical devices include Sinulan sinus relief products and Hedrin head lice treatments. Cosmetics encompass the Oilatum sensitive skin care line and Nizoral Daily Care hair care products. Dietary supplements include Sinulan respiratory products, Lactostad probiotics, and various vitamins and minerals (Biotin, Zinc, Selenium, Vitamin D3). The company's strategic focus areas include pain treatment (Partner in Pain Treatment), biosimilar development, and expansion of the Consumer Healthcare brand portfolio through acquisitions from GSK and Sanofi.

Differentiator

Problem solved

Functional benefit

Brands

• Orofar: Throat lozenges and sprays for sore throat relief and oral infections
• Cholinex
• Nizoral
• ITAMI
• Venoruton
• Oilatum
• Sinulan
• Hedrin
• Elmetacin
• Mobilat
• Hirudoid
• Acodin
• Permen Med

Products and services

• Cholinex® Throat lozenges indicated for inflammation of the oral cavity and throat, throat pain and swelling, and antibiotic therapy for infections of the mucous membrane. Sold OTC through Polish pharmacies for sore throat and oral inflammation relief.
• ITAMI® Self-adhesive plaster containing 140 mg diclofenac for topical use, providing analgesic and anti-inflammatory effects for muscles and joints. Sold OTC through Polish pharmacies.
• Nizoral® Medicinal shampoo containing 20 mg ketoconazole for topical application on skin, indicated for dandruff and fungal infections. Sold OTC through Polish pharmacies.
• Orofar Max Throat lozenges indicated for antiseptic treatment of throat and oral cavity inflammation and relief of pain associated with these conditions. Sold OTC through Polish pharmacies.
• Orofar Junior Throat lozenges for children indicated for oral infections, sore throat associated with colds, pharyngitis, laryngitis, and as adjunctive treatment for tonsillitis. Sold OTC through Polish pharmacies.
• Cynk organiczny 15 mg Organic zinc supplement containing 15 mg per tablet, sold through Polish pharmacies as a dietary supplement.
• Herba-Imuno Herbal immune support supplement, sold through Polish pharmacies as a dietary supplement.
• Orofar® Total Action Spray indicated for oral cavity infections including gum inflammation, infections and ulcers of the oral mucosa (canker sores), and as adjunctive treatment for tonsillitis. Sold OTC through Polish pharmacies.
• Acodin® Cough suppressant containing dextromethorphan indicated for periodic suppression of non-productive (dry) cough from various origins including colds and pleural cough. Sold OTC through Polish pharmacies.
• Acodin® Duo Combines dextromethorphan and dexpanthenol to suppress cough and positively influence regeneration of respiratory mucous membranes. Sold OTC through Polish pharmacies.
• Cholinex® bez cukru Sugar-free throat lozenges indicated for inflammation of the oral cavity and throat, pain and swelling of the throat, and dental treatment of gingival inflammation. Sold OTC through Polish pharmacies.
• Cholinex® Intense Throat lozenges indicated for pain and throat inflammation, available in honey-lemon and blackberry flavors. Sold OTC through Polish pharmacies.
• Elmetacin® External aerosol spray containing 1% indomethacin solution with anti-edema effects for muscles and joints. Sold OTC through Polish pharmacies.
• Hirudoid® Available as ointment and gel, with main component mucopolysaccharide polysulfate, providing anti-inflammatory, antithrombotic, and regenerative effects for venous conditions. Sold OTC through Polish pharmacies.
• Mobilat® Triple-component ointment or gel for topical use containing salicylic acid, adrenal cortex extract, and mucopolysaccharide polysulfate, providing analgesic and anti-edema effects. Sold OTC through Polish pharmacies.
• Nizoral® Krem Cream containing 20 mg/g ketoconazole indicated for topical treatment of fungal skin infections and seborrheic dermatitis. Sold OTC through Polish pharmacies.
• Oilatum® 634 mg/g Bath emulsion indicated for local treatment of irritated, dry, itchy, and flaking skin, also indicated for infant bathing. Sold OTC through Polish pharmacies.
• Permen® Med Forte Used for treating erectile dysfunction in adult men, defined as the inability to obtain or maintain sufficient penile erection for sexual intercourse. Sold OTC through Polish pharmacies.
• Venoruton® forte Tablet medication that protects venous vessels, stabilizes venous walls, and reduces edema. Used for leg edema, venous insufficiency (leg varicose veins), and hemorrhoids. Sold OTC through Polish pharmacies.
• Dabigatran Eteksylan STADA Available in 75mg, 110mg, and 150mg hard capsule forms (Dabigatranum etexilatum), an anticoagulant medication. Dispensed by prescription through Polish pharmacies.
• Palexia Retard Available in 50mg, 100mg, 150mg, 200mg, and 250mg extended-release tablet forms (Tapentadol), an analgesic for moderate to severe pain. Dispensed by prescription through Polish pharmacies.
• Tramal/Tramal Retard Tramadol hydrochloride products available as oral drops (10ml, 96ml) and extended-release tablets (50mg, 100mg, 150mg, 200mg), an analgesic. Dispensed by prescription through Polish pharmacies.
• Transtec Transdermal patch system available in 35μg/h, 52.5μg/h, and 70μg/h doses (Buprenorphinum), for pain management. Dispensed by prescription through Polish pharmacies.
• Versatis 700mg medicated plaster (Lidocainum) for topical pain relief. Dispensed by prescription through Polish pharmacies.
• Axipio Available in 2.5mg and 5mg film-coated tablets (Apixabanum), an anticoagulant medication. Dispensed by prescription through Polish pharmacies.
• Lecytyna Forte 1200mg lecithin supplement for cognitive function support, sold through Polish pharmacies as a dietary supplement.
• Ximluci (Ranibizumab) 10 mg/ml solution for injection, administered by qualified ophthalmologists for intravitreal injections. Dispensed by prescription through specialist ophthalmology channels in Poland.
• Zaldiar 37.5/325mg film-coated tablets (Tramadoli hydrochloridum + Paracetamolum), an analgesic combination medication. Dispensed by prescription through Polish pharmacies.
• Zaldiar Effervescent 37.5/325mg effervescent tablets (Tramadoli hydrochloridum + Paracetamolum), an analgesic combination medication. Dispensed by prescription through Polish pharmacies.
• Kefdensis 60mg Denosumab solution for injection in pre-filled syringes for osteoporosis treatment. Dispensed by prescription through Polish pharmacies and clinics.
• Kinpeygo 4mg Budesonide modified-release hard capsules for kidney disease treatment. Dispensed by prescription through Polish pharmacies and clinics.
• Posaconazole Stada 40 mg/ml oral suspension (Posaconazolum), an antifungal medication. Dispensed by prescription through Polish pharmacies.
• Flexove 625mg Glucosamine film-coated tablets for joint health. Dispensed by prescription through Polish pharmacies.
• Dobroson 7.5mg Zopiclone film-coated tablets for sleep disorders. Dispensed by prescription through Polish pharmacies.
• Acodin® Junior Syrup containing 7.5mg dextromethorphan hydrobromide and 50mg dexpanthenol per 5ml for cough treatment in children. Dispensed by prescription through Polish pharmacies.
• Sinulan Express Forte Product for nasal/sinus relief distributed through Polish pharmacies as a medical device.
• Sinulan Express Forte Junior Junior version of sinus relief product distributed through Polish pharmacies as a medical device.
• Hedrin® OCHRONA Head lice protection product distributed through Polish pharmacies as a medical device.
• Hedrin® SZAMPON Medicated shampoo for head lice treatment distributed through Polish pharmacies as a medical device.
• Hedrin® RAZ Head lice treatment product in gel form distributed through Polish pharmacies as a medical device.
• Nizoral® Daily Care odżywka Nizoral daily conditioner for hair care, sold through Polish pharmacies as a cosmetic.
• Nizoral® Daily Care Szampon Nizoral daily shampoo for regular hair and scalp care, sold through Polish pharmacies as a cosmetic.
• Oilatum® Formuła Zaawansowana Emulsja Advanced formula bath emulsion for sensitive and dry skin, sold through Polish pharmacies as a cosmetic.
• Oilatum® Formuła MED. Krem Medical formula cream for dry and sensitive skin, sold through Polish pharmacies as a cosmetic.
• Oilatum® Codzienna Ochrona Emolient w kostce Daily protection emollient soap bar for gentle cleansing, sold through Polish pharmacies as a cosmetic.
• Oilatum® Codzienna Ochrona Płyn do kąpieli Daily protection bath liquid for moisturizing and skin protection, sold through Polish pharmacies as a cosmetic.
• Oilatum® Codzienna Ochrona Żel do mycia głowy i ciała Daily protection head and body wash gel for gentle cleansing, sold through Polish pharmacies as a cosmetic.
• Sinulan Forte Plant-based preparation supporting proper functioning of the upper respiratory tract, sold through Polish pharmacies as a dietary supplement.
• Sinulan Duo Forte Dual-action formula for respiratory tract support, sold through Polish pharmacies as a dietary supplement.
• Biotyna 300 µg Biotin supplement containing 300 mcg per tablet, sold through Polish pharmacies as a dietary supplement.
• Omega 3-6-9 Combined omega-3, omega-6, and omega-9 fatty acid supplement, sold through Polish pharmacies as a dietary supplement.
• Selen Organiczny Organic selenium supplement containing 100 mcg per tablet, sold through Polish pharmacies as a dietary supplement.
• Sylimarin Max Maximum strength silymarin supplement (150mg) for liver support, sold through Polish pharmacies as a dietary supplement.
• Urinal Intensiv Intensive urinary tract support supplement, sold through Polish pharmacies as a dietary supplement.
• Urinal Standard urinary tract support supplement, sold through Polish pharmacies as a dietary supplement.
• Witamina D3 2000 Vitamin D3 supplement providing 2000 IU per tablet, sold through Polish pharmacies as a dietary supplement.
• Lactostad dla dzieci Probiotic supplement designed for children, sold through Polish pharmacies as a dietary supplement.
• Lactostad dla dorosłych Probiotic supplement designed for adults, sold through Polish pharmacies as a dietary supplement.
• Sinulan plaster aromatyczny Junior Aromatic nasal strip for children for easier breathing during colds, sold through Polish pharmacies.

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

Feature1 record

Partnerships

Nine partnerships are on record, tiered core and minor.

• NEUCAcoreChannel Partner/ Reseller/ Distributor · 13 September 2021NEUCA is the largest pharmaceutical wholesaler in Poland. STADA Poland was the General Partner (Partner Generalny) at the Gala Farmaceuty organized by NEUCA in September 2021 at the Warsaw Hilton hotel. The event was attended by 280 owners representing nearly 1,000 pharmacies, providing STADA with opportunities to showcase its product portfolio and build long-term customer relationships.
• SanoficoreOthers · 1 October 2020STADA finalized the acquisition of approximately a dozen consumer brands from Sanofi in 13 European countries. In Poland, the acquired brands include Modafen and Acodin. The transaction did not include production assets or employees.
• GlaxoSmithKline (GSK)coreOthers · 1 June 2020STADA acquired from GSK a portfolio of 15 OTC products in over 50 countries globally. In Poland, this included the brands Orofar, Cholinex, and Venoruton, significantly expanding STADA Poland's consumer healthcare portfolio.
• WalmarkcoreOthers · 1 March 2020Walmark merged with STADA in March 2020. This merger consolidated employees who were previously working in three different locations into a single unified office under the One STADA philosophy. The Walmark portfolio included brands such as Sinulan Forte and Lactostad.
• AlvotechcoreStrategic or Co-development PartnerAlvotech is a biotech company specializing in biosimilar development. STADA collaborates with Alvotech as part of its biosimilar research program aimed at becoming a key player in the biosimilar segment, particularly for oncology treatments such as filgrastim and pegfilgrastym.
• mAbxience (Insud)coreStrategic or Co-development PartnerPart of STADA's biosimilar development collaboration program. mAbxience specializes in biosimilar monoclonal antibodies. STADA aims to leverage this partnership to expand its presence in the biosimilar segment.
• XbranecoreStrategic or Co-development PartnerXbrane collaborates with STADA on biosimilar development. This partnership is part of STADA's strategy to build capabilities in the biosimilar market segment.
• Johnson & JohnsoncoreOthersSTADA acquired the Nizoral brand from Johnson & Johnson as part of its expansion of the consumer healthcare portfolio in Poland.
• KantarminorOthersKantar is the market research agency commissioned by STADA to conduct the annual STADA Health Report. The 2021 edition surveyed 30,000 respondents from 15 European countries including Poland on health-related topics including pandemic effects on daily life.

Scale indicators6 records

Recent moves8 records

Expansion highlights4 records

Direct peers

• Polpharma: Poland's largest generic pharmaceutical manufacturer, producing prescription generics, OTC, and dietary supplements with a similarly broad therapeutic portfolio and pharmacy-led distribution model — directly comparable to STADA Poland's two-pillar strategy.
• Teva Poland: Teva is the world's leading generics company and a top-tier player in the Polish prescription generic and specialty market. It competes head-on with STADA Poland across therapeutic categories and pharmacy channels.
• Sandoz Poland (Novartis): Sandoz is Novartis's generics division and a major prescription generic and biosimilar competitor in Poland. It mirrors STADA Poland's generic-plus-specialty positioning, particularly in biosimilars.
• KRKA Poland: KRKA is a Slovenian generic and OTC pharmaceutical group with a strong Polish subsidiary. It competes with STADA Poland across prescription generics, OTC, and self-medication categories.
• Gedeon Richter Poland: Gedeon Richter's Polish subsidiary markets a broad portfolio of generics and specialty pharmaceuticals, including CNS and women's health. It is a comparable Eastern European generic peer with similar pharmacy-led distribution.
• Viatris Poland (formerly Mylan): Viatris is a global generics and specialty player with a Polish commercial presence, directly competing with STADA Poland in generic prescriptions and selected OTC categories.
• Zentiva Poland: Zentiva (formerly Sanofi's European generics business) is a pan-European generic manufacturer with a Polish footprint, directly competing with STADA Poland across generic Rx and self-medication.

Regional players

• USP Zdrowie (Pelion): USP Zdrowie is a major Polish OTC, supplement, and cosmetics manufacturer, part of the Pelion group that also operates the CEPD/wholesale network. It is a strong domestic peer with overlapping OTC and dietary supplement categories.
• Aflofarm Poland: Aflofarm is one of the leading Polish OTC and dietary supplement manufacturers with strong domestic brands (e.g., Apap, Strepsils-adjacent SKUs). It is a regional OTC/supplement peer that competes for pharmacy shelf space and consumer mindshare.

Broad incumbents

• Perrigo Poland: Perrigo is a global OTC and self-care leader; its Polish subsidiary markets OTC and consumer healthcare products (e.g., Analgesics, cold & flu). It is a broad incumbent comparable in OTC portfolio shape and pharmacy-channel go-to-market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/c/StadaPoland
• LinkedInlinkedin.com/company/stada-poland

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about STADA Poland